Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis

Gynecologic Oncology

Volumn 90, Issue 2, 2003, Pages 372-377

  Amant, Frederic ^a   Vloeberghs, Veerle ^a   Woestenborghs, Heidi ^a   Moerman, Philippe ^a   Vergote, Ignace ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carcinosarcoma; Histogenesis; Metaplasia; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CANCER GROWTH; CANCER RECURRENCE; CARCINOGENESIS; CARCINOMA CELL; CARCINOSARCOMA; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; OVARY METASTASIS; PHENOTYPE; PRIORITY JOURNAL; SARCOMA CELL; TUMOR DIFFERENTIATION;

EID: 0041622831     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00326-3     Document Type: Article

References (21)

1. Seidman J.D., Russell P., Kurman R.J. Surface epithelial tumors of the ovary. Kurman R.J. Blaustein's pathology of the female genital tract. 5th ed:2002;791-886 Springer-Verlag, New York.
2. Zelmanowicz A., Hildeseim A., Sherman M.E., Sturgeon S.R., Kurman R.J., Barrett R.J., et al. Evidence for a common etiology for endometrial carcinomas and malignant mixed Mullerian tumors. Gynecol Oncol. 69:1998;253-257.
3. Bitterman P., Chun B., Kurman R.J. The significance of the epithelial differentiation in mixed mesodermal tumors of the uterus. Am J Surg Pathol. 14:1990;317-328.
4. Silverberg S.G., Major F.J., Blessing J.A., Fetter B., Askin F.B., Liao S., et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecological Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol. 9:1990;1-19.
5. Shreenan J.J., Hart W.R. Carcinosarcomas of the femal genital tract. A pathologic study of 29 metastatic tumors further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis . Am J Surg Pathol. 19:1995;666-674.
6. Meis J.M., Lawrence W.D. The immunohistochemical profile of malignant mixed Müllerian tumor. Am J Clin Pathol. 94:1990;1-7.
7. Abeln E.C.A., Smit V.T.H.B.M., Wessels J.W., De Leeuw W.J.F., Cornelisse C.J., Fleuren G.J. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumours. J Pathol. 183:1997;424-431.
8. Kounelis S., Jones M.W., Papadaki H., Bakker A., Swalsky P., Finkelstein S.D. Carcinosarcomas (malignant mixed müllerian tumors) of the femal genital tract comparative molecular analysis of epithelial and mesenchymal components . Hum Pathol. 29:1998;82-87.
9. Masuda A., Takeda A., Fukami F., Yamada C., Matsuyama M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Cancer. 60:1987;2696-2703.
10. Emoto M., Iwasaki H., Kikuchi M., Shirakawa K. Characteristics of cloned cells of mixed Müllerian tumor of the human uterus. Cancer. 71:1993;3065-3075.
11. de Brito P.A., Siverberg S.G., Orenstein J.M. Carcinosarcoma (malignant mixed Müllerian (mesodermal) tumor) of the femal genital tract. Hum Pathol. 24:1993;132-142.
12. Ariyoshi K., Kawauchi S., Kaku T., Nakano M., Tsuneyoshi M. Prognostic factors in ovarian carcinosarcoma a clinicopathological and immunohistochemical analysis of 23 cases . Histopathology. 37:2000;427-436.
13. Costa M.J., Walls J. Epidermal growth factor receptor and c-erB-2 oncoprotein expression in femal genital tract carcinosarcomas (malignant mixed Müllerian tumors) clinicopathologic study of 82 cases . Cancer. 77:1996;535-542.
14. Sonoda Y., Saigo P.E., Federici M.G., Boyd J. Case report carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin . Gynecol Oncol. 76:2000;226-229.
15. Czernobilsky B., LaBarre G.C. Carcinosarcoma and mixed mesodermal tumor of the ovary. A clinicopathologic analysis of 9 cases. Obstet Gynecol. 31:1968;21-27.
16. Dehner L.P., Norris H.J., Taylor H.B. Carcinosarcomas and mixed mesodermal tumors of the ovary. Cancer. 27:1971;207-216.
17. Dihn T.V., Slavin R.E., Bhagavan B.S., Hannigan E.V., Tiamson E.M., Yandell R.B. Mixed mesodermal tumors of the ovary a clinicopathologic study of 14 cases . Obstet Gynecol. 72:1988;409-412.
18. Plaxe S.C., Dottino P.R., Goodman H.M., Deligdisch L., Idelson M., Cohen C.J. Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy. Gynecol Oncol. 37:1990;244-249.
19. Barakat R.R., Rubin S.C., Wong G., Sagio P.E., Markman M., Hoskins W.J. Mixed mesodermal tumor of the ovary analysis of prognostic factors in 31 cases . Obstet Gynecol. 80:1992;660-664.
20. Muntz H.G., Jones M.A., Goff B.A., Fuller A.F., Nikrui N., Rice L.W., et al. Malignant mixed Müllerian tumors of the ovary. Experience with surgical cytoreduction and combination chemotherapy. Cancer. 76:1995;1209-1213.
21. Möbus V.J., Gerharz C.D., Weikel W., Merk O., Dreher L., Kreienberg R., et al. Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation. Gynecol Oncol. 83:2001;523-532.